Rochester, NY (PRWEB) September 23, 2013
An article in the Jerusalem Post reported on a recent meeting “in Tel Aviv 10 days ago of 40 leading experts on gynecology, oncology, women’s health, vaccines and other specialties who discussed the pros and cons of the HPV vaccine (1).” At the meeting, Dr. Uzi Beller, an international authority on gynecological cancers, “was the main voice urging caution (1).”
“I want to see fundamental studies proving efficacy, and they do not exist (1).” The vaccines, Beller said, “were tested on mostly white women attending colleges and university – mostly from developed countries and healthy. The data were based on a relatively short term follow-up period. What is known does not yet justify widespread vaccination of healthy girls (1).”
In addition, Dr. Beller said that “there is no evidence that prophylactic (preventative) vaccination against HPV types 16 and 18 reduces the incidence of cervical cancer,” Beller declared. As the vaccine costs $100 to $360 for three doses in wealthy countries, it is completely out of the reach of developing countries, where an effective vaccine would be most urgently needed (1).”
The Jerusalem Post report concluded that “pediatricians are important advocates for preventive medicine, but they may know little about HPV infection and cervical and other HPV-related cancers. Obstetricians / Gynecologists know about HPV and cervical cancer prevention, but they often know little about vaccines and immunization delivery (1).”
“We believe doctors need facts. Many times, they’re recommending vaccination to their patients because that’s the shpiel they get from the CDC and the FDA. We believe many doctors would choose to recommend a more natural approach if they could be sure of that approach’s safety and efficacy. We’re happy to say that a study conducted by the Center for the Biology of Chronic Disease (CBCD) showed exactly that.” – Mike Evans, polyDNA
A recent post marketing clinical study published in the peer reviewed, medical journal Pharmacology & Pharmacy, in a special edition on Advances in Antiviral Drugs on August 12, 2013 showed that Gene-Eden-VIR reduced HPV symptoms and was safe and effective (2). “Up to 70% of those studied reported a decrease in viral symptoms (2).”
Each ingredient of Gene-Eden-VIR was chosen through a scientific approach. Scientists scanned thousands of scientific and medical papers published in various medical and scientific journals around the world to identify the safest, most effective natural ingredients that target the latent form of herpes (2).
Doctors can view the paper on Gene-Eden-VIR here: http://www.scirp.org/journal/PaperInformation.aspx?PaperID=36101
To learn more about Gene-Eden-VIR and HPV, visit http://www.gene-eden-kill-virus.com/Herpes-Remedy.php. All orders of Gene-Eden-VIR are completely confidential, and no information is shared or sold to any third party. Privacy is assured.
polyDNA is a biotechnology company that develops dietary supplements using the unique scientific method developed by Dr. Hanan Polansky, which is based on Computer Intuition.
In addition to his unique scientific method, Dr. Polansky published the highly acclaimed scientific discovery, called Microcompetition with Foreign DNA. The discovery explains how foreign DNA fragments, and specifically, DNA of latent viruses, cause most major diseases.
polyDNA developed Gene-Eden-VIR , an antiviral natural remedy that helps the immune system kill latent viruses.